Intra-Cellular Therapies
ITCI
#1292
Rank
C$20.09 B
Marketcap
$188.97
Share price
-0.08%
Change (1 day)
115.20%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -$2.17

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -$2.32. In 2022 the company made an earnings per share (EPS) of -$3.92 an increase over its 2021 EPS that were of -$5.04.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.17-44.62%
2022-$3.92-22.29%
2021-$5.048.02%
2020-$4.6620.9%
2019-$3.86-5.63%
2018-$4.0933.96%
2017-$3.05-21.19%
2016-$3.87-7.56%
2015-$4.19174.53%
2014-$1.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.36-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-$14.40 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.08 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA